- Truist analyst Michael Ciarmoli initiated coverage of Howmet Aerospace Inc (NYSE:HWM) with a Buy rating and a price target of $41, implying an upside of 31.5%.
- The analyst says that HWM is a unique and differentiated asset in the aerospace supply chain.
- Ciarmoli notes that Howmet can benefit from growing aircraft production rates, share gains in the titanium aerospace market, and an easing supply chain in the transportation market.
- Price Action: HWM shares are trading higher by 0.27% at $31.18 on the last check Wednesday.
Rocket Pharmaceuticals Announces Proposed Public Offering Of $100M Of Shares Of Its Common Stock
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of investigational genetic therapies for rare childhood disorders with high
